About Emil Pharmaceuticals
Emil Pharmaceuticals is a company based in Mumbai (India) founded in 1989. It operates as a Reseller / Distribution. Emil Pharmaceuticals has raised $14.64 million across 1 funding round from investors including Somerset Indus Capital Partners. The company has 81 employees as of March 04, 2025. Emil Pharmaceuticals offers products and services including Pharmaceutical Products.
- Headquarter Mumbai, India
- Employees 81 as on 04 Mar, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emil Pharmaceutical Industries Private Limited
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$18.42 M (USD)-23.27as on Mar 31, 2024
-
Net Profit
$1.6 M (USD)-57as on Mar 31, 2024
-
EBITDA
$3.04 M (USD)-51.36as on Mar 31, 2024
-
Total Equity Funding
$14.64 M (USD)
in 1 rounds
-
Latest Funding Round
$14.64 M (USD), Series B
Apr 17, 2023
- Investors
-
Employee Count
81
as on Mar 04, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emil Pharmaceuticals
Emil Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products.
Medicines are manufactured for various multinational pharmaceutical companies.
Funding Insights of Emil Pharmaceuticals
Emil Pharmaceuticals has successfully raised a total of $14.64M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.64 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Emil Pharmaceuticals
Emil Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Somerset Indus Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments focused on accessibility, affordability, and ESG integration in India.
|
Locked | Locked | Locked |
Investor details for Emil Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emil Pharmaceuticals
Investment portfolio details for Emil Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emil Pharmaceuticals
Detailed financials for Emil Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emil Pharmaceuticals Comparisons
Peer comparison for Emil Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emil Pharmaceuticals
Detailed competitors of Emil Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emil Pharmaceuticals
Complete news archive for Emil Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emil Pharmaceuticals
Emil Pharmaceuticals was founded in 1989 and raised its 1st funding round 34 years after it was founded.
Emil Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Shrirang Gadnis is the current CEO of Emil Pharmaceuticals.
Emil Pharmaceuticals is a funded company, having raised a total of $14.64M across 1 funding round to date.
As of Mar 04, 2025, the latest employee count at Emil Pharmaceuticals is 81.
Annual revenue of Emil Pharmaceuticals is $18.42M as on Mar 31, 2024.
Emil Pharmaceuticals is engaged in the manufacture of quality medicines for multinational companies such as Pfizer, Merck, and Novartis. Operations are conducted across two units with high-quality standards. Products are distributed to international markets including South and Central America, Africa, Southeast Asia, and CIS nations. Services include contract manufacturing, product development, and technology transfer. The company is focused on maintaining unmatched quality in the pharmaceutical sector.
Emil Pharmaceuticals offers Pharmaceutical Products.
Emil Pharmaceuticals has 1 investor. Key investors include Somerset Indus Capital Partners.